Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (241-250 of 316) with videos related to

Pageof 32
Sort By:
Radiation Oncology (London, England)|September 26, 2012
ACR appropriateness criteria®  resectable rectal cancerWilliam E Jones, Charles R Thomas, Joseph M Herman, et al.
Oncology (Williston Park, N.Y.)|July 17, 2016
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer, William Small, John P Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2021
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic AdenocarcinomaWilliam A Hall, Laura A Dawson, Theodore S Hong, et al.
Annals of Surgical Oncology|January 21, 2010
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu, Joseph M Herman, Michele M Corsini, et al.
Pancreas|January 13, 2018
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant ChemoradiationJoseph M Herman, Salma K Jabbour, Steven H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
American Journal of Clinical Oncology|August 10, 2022
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and GuidelinesRachit Kumar, Leila Tchelebi, Christopher J Anker, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancerAlessio G Morganti, Massimo Falconi, Ruud G P M van Stiphout, et al.
Advances in Radiation Oncology|October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapyZhi Cheng, Lauren M Rosati, Linda Chen, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
Pageof 32

Showing results (241-250 of 316) with videos related to

Sort By:
Pageof 32
Radiation Oncology (London, England)|September 26, 2012
ACR appropriateness criteria®  resectable rectal cancerWilliam E Jones, Charles R Thomas, Joseph M Herman, et al.
Oncology (Williston Park, N.Y.)|July 17, 2016
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer, William Small, John P Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2021
Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic AdenocarcinomaWilliam A Hall, Laura A Dawson, Theodore S Hong, et al.
Annals of Surgical Oncology|January 21, 2010
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu, Joseph M Herman, Michele M Corsini, et al.
Pancreas|January 13, 2018
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant ChemoradiationJoseph M Herman, Salma K Jabbour, Steven H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
American Journal of Clinical Oncology|August 10, 2022
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and GuidelinesRachit Kumar, Leila Tchelebi, Christopher J Anker, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancerAlessio G Morganti, Massimo Falconi, Ruud G P M van Stiphout, et al.
Advances in Radiation Oncology|October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapyZhi Cheng, Lauren M Rosati, Linda Chen, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
Pageof 32